JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
FDMT Financials - 4d Molecular Therapeutics Income & Cash Flow | Ledgeburg
FDMT - 4d Molecular Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary FDMT Stock
Financials
Financials FDMT Stock
Loading...
Loading...
Income Statement
Income Statement FDMT Stock
Balance Sheet
Balance Sheet FDMT Stock
Cash Flow Statement
Cash Flow Statement FDMT Stock
Loading...
Loading...
Home
Stocks
4d Molecular Therapeutics, Inc. (FDMT)
Financials
Financials of FDMT
Loading...
Loading...
Loading...
Loading...
Revenue
$85.209M
Operating Income
$-159.547M
Net Income
$-140.109M
Share Count (Basic)
57.93018M
Operating Cash Flow
$-109.082M
Free Cash Flow
$-109.618M
Cash And Short-Term Equivalents
$402.655M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
20M
40M
60M
80M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-160M
-140M
-120M
-100M
-80M
Annual
Quarterly
Margins
Gross
Operating
Net
-500000%
-400000%
-300000%
-200000%
-100000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-60M
-40M
-20M
0
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-400000%
-300000%
-200000%
-100000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26